Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,400
Closed -$378K 967
2017
Q1
$378K Buy
+7,400
New +$353K ﹤0.01% 1619
2016
Q4
Sell
-4,400
Closed -$209K 2192
2016
Q3
$209K Sell
4,400
-2,200
-33% -$110K ﹤0.01% 1860
2016
Q2
$333K Sell
6,600
-1,000
-13% -$50.5K ﹤0.01% 1765
2016
Q1
$367K Sell
7,600
-4,100
-35% -$158K ﹤0.01% 1694
2015
Q4
$460K Sell
11,700
-900
-7% -$36K ﹤0.01% 1738
2015
Q3
$478K Sell
12,600
-18,600
-60% -$784K ﹤0.01% 1813
2015
Q2
$1.24M Sell
31,200
-1,800
-5% -$56.1K 0.01% 1378
2015
Q1
$884K Buy
33,000
+3,200
+11% +$90.3K ﹤0.01% 1485
2014
Q4
$875K Buy
29,800
+9,000
+43% +$222K ﹤0.01% 1527
2014
Q3
$420K Sell
20,800
-20,400
-50% -$394K ﹤0.01% 2087
2014
Q2
$690K Buy
41,200
+16,100
+64% +$228K ﹤0.01% 1893
2014
Q1
$374K Buy
25,100
+800
+3% +$12.3K ﹤0.01% 2228
2013
Q4
$356K Sell
24,300
-75,400
-76% -$1.21M ﹤0.01% 2522
2013
Q3
$1.72M Buy
99,700
+80,400
+417% +$1.19M 0.01% 1565
2013
Q2
$224K Buy
+19,300
New +$221K ﹤0.01% 2962

Other funds holding AMED

Timber Hill's AMED Position: Q1 2014 in Review

Timber Hill sold out of Amedisys (AMED) in Q1 2014, closing a stake of 15,243 shares — an estimated $235K sold.

Timber Hill first reported a position in AMED in Q4 2013 and held it in 1 quarter. The position peaked at $223K in Q4 2013. 120 funds tracked by Wall St. Rank hold AMED as of Q1 2014.

  • Timber Hill reported no remaining Amedisys position as of Q1 2014 after selling out during the quarter.
  • Timber Hill sold 15,243 Amedisys shares in Q1 2014, an estimated $235K.
  • Timber Hill first reported a position in Amedisys in Q4 2013 and held it in 1 quarter.
  • Timber Hill's Amedisys position peaked at $223K in Q4 2013.
  • 120 funds tracked by Wall St. Rank held Amedisys as of Q1 2014.

Based on Timber Hill's 13F filing for Q1 2014, filed 13 May 2014.